ZIMMER BIOMET HOLDINGS, INC.

Income statement revenue $2.18B (+4.8% YoY).Operating income $326.1M (+8.7% YoY).Pre-tax result $255.1M (+13.6% YoY).Net result $199.6M (+30.1% YoY).

• Hips: $562.7M (+5.0% YoY)
• Knees: $828.9M (+0.4% YoY)
• SET: $586M (+6.4% YoY)
• Technology And Data Bone Cement And Surgical: $199.4M (+21.1% YoY)
• Intangible asset amortization: $163.4M (+1.7% YoY)
• Research and development: $104.8M (-7.5% YoY)
• Selling, general and administrative: $899.3M (+10.4% YoY)
• Restructuring and other cost reduction initiatives: $29.8M (+70.3% YoY)
• Acquisition, integration, divestiture and related: $18.1M (-77.1% YoY)
• Other expense: $71M (-5.8% YoY)
• Income tax expense: $55.5M (-22.1% YoY)